Thrombotic and hemorrhagic events in 2016 World Health Organization-defined Philadelphia-negative myeloproliferative neoplasm

Background/Aims Recent changes in the diagnostic criteria for myeloproliferative neoplasms (MPNs) and increasing patient numbers necessitate updating of the data on vascular events in patients with such disorders. Methods In this single-center study, thrombotic and hemorrhagic events were retrospect...

Full description

Bibliographic Details
Main Authors: Ik-Chan Song, Sang Hoon Yeon, Myung-Won Lee, Hyewon Ryu, Hyo-Jin Lee, Hwan-Jung Yun, Seon Young Kim, Deog-Yeon Jo
Format: Article
Language:English
Published: The Korean Association of Internal Medicine 2021-09-01
Series:The Korean Journal of Internal Medicine
Subjects:
Online Access:http://www.kjim.org/upload/pdf/kjim-2020-634.pdf
id doaj-1171ae3cdf6c42e4a204252610a84058
record_format Article
spelling doaj-1171ae3cdf6c42e4a204252610a840582021-09-13T01:34:22ZengThe Korean Association of Internal MedicineThe Korean Journal of Internal Medicine1226-33032005-66482021-09-013651190120310.3904/kjim.2020.634170548Thrombotic and hemorrhagic events in 2016 World Health Organization-defined Philadelphia-negative myeloproliferative neoplasmIk-Chan Song0Sang Hoon Yeon1Myung-Won Lee2Hyewon Ryu3Hyo-Jin Lee4Hwan-Jung Yun5Seon Young Kim6Deog-Yeon Jo7 Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea Department of Laboratory Medicine, Chungnam National University College of Medicine, Daejeon, Korea Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, KoreaBackground/Aims Recent changes in the diagnostic criteria for myeloproliferative neoplasms (MPNs) and increasing patient numbers necessitate updating of the data on vascular events in patients with such disorders. Methods In this single-center study, thrombotic and hemorrhagic events were retrospectively analyzed in patients diagnosed with essential thrombocythemia (ET), polycythemia vera (PV) prefibrotic/early primary myelofibrosis (pre-PMF), or PMF, based on the 2016 World Health Organization diagnostic criteria. Results Of a total of 335 consecutive patients (139 ET, 42 pre-PMF, 124 PV, and 30 PMF patients; 192 males and 143 females) of median age 64 years (range, 15 to 91), 112 (33.4%) experienced a total of 126 thrombotic events before diagnosis, at the time of diagnosis, or during follow-up over a median of 4.6 years (range, 0.1 to 26.5). Cerebrovascular thrombosis (18.8%) was the most common initial event, followed by coronary heart disease (10.1%) and splanchnic (1.5%) and peripheral thrombosis (1.5%). Arterial thrombosis was more common than venous thrombosis (31.3% vs. 2.1%, respectively; p = 0.001). Thrombosis was most frequent in PV patients (39.5%), followed by patients with pre-PMF (38.1%), ET (30.9%), and PMF (13.3%). Of the 112 patients who experienced thromboses, 53 (47%) and 39 (33.9%) had thrombotic events before and at the time of MPN diagnosis, respectively. Twenty-seven patients (8.1%) experienced 29 hemorrhagic events, of which gastrointestinal bleeding (n = 20) was the most common. Conclusions Most thrombotic events occurred before or at the time of diagnosis, and the prevalence of arterial thrombosis was markedly higher than that of venous thrombosis in patients with MPN.http://www.kjim.org/upload/pdf/kjim-2020-634.pdfmyeloproliferative neoplasmthrombocythemiaessentialpolycythemia verathrombosishemorrhage
collection DOAJ
language English
format Article
sources DOAJ
author Ik-Chan Song
Sang Hoon Yeon
Myung-Won Lee
Hyewon Ryu
Hyo-Jin Lee
Hwan-Jung Yun
Seon Young Kim
Deog-Yeon Jo
spellingShingle Ik-Chan Song
Sang Hoon Yeon
Myung-Won Lee
Hyewon Ryu
Hyo-Jin Lee
Hwan-Jung Yun
Seon Young Kim
Deog-Yeon Jo
Thrombotic and hemorrhagic events in 2016 World Health Organization-defined Philadelphia-negative myeloproliferative neoplasm
The Korean Journal of Internal Medicine
myeloproliferative neoplasm
thrombocythemia
essential
polycythemia vera
thrombosis
hemorrhage
author_facet Ik-Chan Song
Sang Hoon Yeon
Myung-Won Lee
Hyewon Ryu
Hyo-Jin Lee
Hwan-Jung Yun
Seon Young Kim
Deog-Yeon Jo
author_sort Ik-Chan Song
title Thrombotic and hemorrhagic events in 2016 World Health Organization-defined Philadelphia-negative myeloproliferative neoplasm
title_short Thrombotic and hemorrhagic events in 2016 World Health Organization-defined Philadelphia-negative myeloproliferative neoplasm
title_full Thrombotic and hemorrhagic events in 2016 World Health Organization-defined Philadelphia-negative myeloproliferative neoplasm
title_fullStr Thrombotic and hemorrhagic events in 2016 World Health Organization-defined Philadelphia-negative myeloproliferative neoplasm
title_full_unstemmed Thrombotic and hemorrhagic events in 2016 World Health Organization-defined Philadelphia-negative myeloproliferative neoplasm
title_sort thrombotic and hemorrhagic events in 2016 world health organization-defined philadelphia-negative myeloproliferative neoplasm
publisher The Korean Association of Internal Medicine
series The Korean Journal of Internal Medicine
issn 1226-3303
2005-6648
publishDate 2021-09-01
description Background/Aims Recent changes in the diagnostic criteria for myeloproliferative neoplasms (MPNs) and increasing patient numbers necessitate updating of the data on vascular events in patients with such disorders. Methods In this single-center study, thrombotic and hemorrhagic events were retrospectively analyzed in patients diagnosed with essential thrombocythemia (ET), polycythemia vera (PV) prefibrotic/early primary myelofibrosis (pre-PMF), or PMF, based on the 2016 World Health Organization diagnostic criteria. Results Of a total of 335 consecutive patients (139 ET, 42 pre-PMF, 124 PV, and 30 PMF patients; 192 males and 143 females) of median age 64 years (range, 15 to 91), 112 (33.4%) experienced a total of 126 thrombotic events before diagnosis, at the time of diagnosis, or during follow-up over a median of 4.6 years (range, 0.1 to 26.5). Cerebrovascular thrombosis (18.8%) was the most common initial event, followed by coronary heart disease (10.1%) and splanchnic (1.5%) and peripheral thrombosis (1.5%). Arterial thrombosis was more common than venous thrombosis (31.3% vs. 2.1%, respectively; p = 0.001). Thrombosis was most frequent in PV patients (39.5%), followed by patients with pre-PMF (38.1%), ET (30.9%), and PMF (13.3%). Of the 112 patients who experienced thromboses, 53 (47%) and 39 (33.9%) had thrombotic events before and at the time of MPN diagnosis, respectively. Twenty-seven patients (8.1%) experienced 29 hemorrhagic events, of which gastrointestinal bleeding (n = 20) was the most common. Conclusions Most thrombotic events occurred before or at the time of diagnosis, and the prevalence of arterial thrombosis was markedly higher than that of venous thrombosis in patients with MPN.
topic myeloproliferative neoplasm
thrombocythemia
essential
polycythemia vera
thrombosis
hemorrhage
url http://www.kjim.org/upload/pdf/kjim-2020-634.pdf
work_keys_str_mv AT ikchansong thromboticandhemorrhagiceventsin2016worldhealthorganizationdefinedphiladelphianegativemyeloproliferativeneoplasm
AT sanghoonyeon thromboticandhemorrhagiceventsin2016worldhealthorganizationdefinedphiladelphianegativemyeloproliferativeneoplasm
AT myungwonlee thromboticandhemorrhagiceventsin2016worldhealthorganizationdefinedphiladelphianegativemyeloproliferativeneoplasm
AT hyewonryu thromboticandhemorrhagiceventsin2016worldhealthorganizationdefinedphiladelphianegativemyeloproliferativeneoplasm
AT hyojinlee thromboticandhemorrhagiceventsin2016worldhealthorganizationdefinedphiladelphianegativemyeloproliferativeneoplasm
AT hwanjungyun thromboticandhemorrhagiceventsin2016worldhealthorganizationdefinedphiladelphianegativemyeloproliferativeneoplasm
AT seonyoungkim thromboticandhemorrhagiceventsin2016worldhealthorganizationdefinedphiladelphianegativemyeloproliferativeneoplasm
AT deogyeonjo thromboticandhemorrhagiceventsin2016worldhealthorganizationdefinedphiladelphianegativemyeloproliferativeneoplasm
_version_ 1717381565377413120